Researchers analysing Global Burden of Disease Study 2021 data reported blindness-related burden will continue to increase as populations age. The analysis, published in The Lancet Global Health, asse
New Zealand’s first dedicated school vision bus, Celia, is set to launch within weeks, bringing free eye exams to children who would otherwise go without.
Minor salivary gland transplantation (MSGT) is a promising surgical option for patients with severe dry eye disease (DED) where tear production is absent, especially for those with Stevens-Johnson syndrome, according to US ophthalmologists.
Two studies presented at the recent 43rd Congress of the European Society of Cataract and Refractive Surgeons found immediate sequential bilateral cataract surgery (ISBCS) to be safe, practical and often associated with better visual outcomes than delayed sequential bilateral cataract surgery (DSBCS
Researchers at the University of Auckland found “significant inconsistencies” in the way clinicians manage patients with blind disfigured eyes, specifically regarding the provision and care of custom scleral-shell prostheses.
A recent survey for Johnson & Johnson Vision uncovered a significant gap in how middle-aged Australians understand and manage presbyopia. It found the condition is often overlooked or under-treated, p
US researchers found patients prescribed glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as Ozempic and Wegovy, had about half the risk of developing non-infectious uveitis compared with ma
Norway is incorporating AI-powered eye screening in its national health system to address ophthalmologist shortages and reduce preventable blindness from diabetes. Partnering with Eyenuk, a US-
Five new projects funded by the Australian and New Zealand Eye Foundation (ANZEF, the philanthropic arm of RANZCO) will investigate eye-health inequities across New Zealand and the Pacific, focusing on screening, service access, treatment participation and clinical trial inclusion.
A Pharmac proposal to fund four new medicines from Roche, including the anti-VEGF treatment Vabysmo (faricimab) for neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular oedema (DMO), resulted in several hastily despatched submissions from the eyecare industry.
Researchers at China’s Fudan University found almost two-thirds of glaucoma patients struggle to instil eye drops correctly, with self-reported confidence often not matching observed technique. P
Marking World Sight Day, Eye Health Aotearoa (EHA) brought eye health to the heart of the New Zealand Government with a clear message: eye checks save sight.
